GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » Sale Of Investment

Polaris AI Pharma (XKRX:041910) Sale Of Investment : ₩0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Polaris AI Pharma Sale Of Investment?

Polaris AI Pharma's sale of investment for the three months ended in Sep. 2024 was ₩0 Mil. It means Polaris AI Pharma gained ₩0 Mil from selling investments. Polaris AI Pharma's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ₩0 Mil.

Compared with last quarter (₩0 Mil in Jun. 2024 ), Polaris AI Pharma gained the same money from selling investments in Sep. 2024 (₩0 Mil).

Polaris AI Pharma Sale Of Investment Historical Data

The historical data trend for Polaris AI Pharma's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris AI Pharma Sale Of Investment Chart

Polaris AI Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,402.38 10,420.72 8,478.42 5,218.00 13,312.53

Polaris AI Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Polaris AI Pharma Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polaris AI Pharma Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Polaris AI Pharma's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Polaris AI Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » Sale Of Investment
Comparable Companies
XKRX:200230 XKRX:000220 XKRX:001540 XKRX:204840 XKRX:142280 XKRX:012790 XKRX:007370 XKRX:175250 XKRX:239610 XKRX:067290 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
N/A
Address
25 Balangongdan-ro, Hyangnam-eup, Gyeonggi-do, Hwaseong-si, KOR
Website
https://www.polarisaipharma.com
Polaris AI Pharma Corp is engaged in the production of raw pharmaceutical ingredients. It focuses on generic drugs and produces about 40 types of raw medicines, including asthma treatments, gastric ulcer treatments, and alcohol dependence treatments, and supplies them domestically and internationally.

Polaris AI Pharma Headlines

No Headlines